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Calmodulin-binding transcription activator 1 (CAMTA1) alleles
predispose human episodic memory performance
Abstract
Little is known about the genes and proteins involved in the process of human memory. To identify
genetic factors related to human episodic memory performance, we conducted an ultra-high-density
genome-wide screen at > 500 000 single nucleotide polymorphisms (SNPs) in a sample of normal young
adults stratified for performance on an episodic recall memory test. Analysis of this data identified SNPs
within the calmodulin-binding transcription activator 1 (CAMTA1) gene that were significantly
associated with memory performance. A follow up study, focused on the CAMTA1 locus in an
independent cohort consisting of cognitively normal young adults, singled out SNP rs4908449 with a
P-value of 0.0002 as the most significant associated SNP in the region. These validated genetic findings
were further supported by the identification of CAMTA1 transcript enrichment in memory-related
human brain regions and through a functional magnetic resonance imaging experiment on individuals
matched for memory performance that identified CAMTA1 allele-specific upregulation of medial
temporal lobe brain activity in those individuals harboring the 'at-risk' allele for poorer memory
performance. The CAMTA1 locus encodes a purported transcription factor that interfaces with the
calcium-calmodulin system of the cell to alter gene expression patterns. Our validated genomic and
functional biological findings described herein suggest a role for CAMTA1 in human episodic memory.
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Little is known about the genes and proteins involved in the process of human memory. To identify genetic
factors related to human episodic memory performance, we conducted an ultra-high-density genome-wide
screen at >500 000 single nucleotide polymorphisms (SNPs) in a sample of normal young adults stratified
for performance on an episodic recall memory test. Analysis of this data identified SNPs within the
calmodulin-binding transcription activator 1 (CAMTA1) gene that were significantly associated with
memory performance. A follow up study, focused on the CAMTA1 locus in an independent cohort consisting
of cognitively normal young adults, singled out SNP rs4908449 with a P-value of 0.0002 as the most signifi-
cant associated SNP in the region. These validated genetic findings were further supported by the identifi-
cation of CAMTA1 transcript enrichment in memory-related human brain regions and through a functional
magnetic resonance imaging experiment on individuals matched for memory performance that identified
CAMTA1 allele-specific upregulation of medial temporal lobe brain activity in those individuals harboring
the ‘at-risk’ allele for poorer memory performance. The CAMTA1 locus encodes a purported transcription
factor that interfaces with the calcium-calmodulin system of the cell to alter gene expression patterns. Our
validated genomic and functional biological findings described herein suggest a role for CAMTA1 in
human episodic memory.
INTRODUCTION
Human memory is a demonstrated, complex heritable trait,
and multiple lines of evidence from twin studies suggest
50% of phenotypic differences in memory among individ-
uals is because of heritable factors (1). One form of human
memory, known as episodic memory, involves in the con-
scious retrieval of prior experiences (2). Regions of the
medial temporal lobe, including the hippocampus, are gener-
ally considered to play critical roles in episodic memory for-
mation and retrieval, and pathology in these regions (e.g. in
patients with Alzheimer’s disease; AD) is typically associ-
ated with memory loss (3). Although researchers have
gained important insights about the cognitive operations
and brain regions associated with episodic memory and
other memory systems, relatively little is known about the
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genes and proteins involved in the complex process of
memory formation.
Recent candidate-gene association studies have identified
variations in multiple genes such as protein kinase C (PKC),
protein kinase A (PKA), brain derived neurotrophic factor
(BDNF) and serotonin receptor 2A (HTR2A) that have a
significant impact on memory aptitude, in a candidate-gene
fashion (4–6). Advances in the development of ultra-high-
density genotyping platforms (.500 000 single nucleotide
polymorphisms; SNPs) now greatly facilitate whole genome
association studies for complex diseases (7,8). Recently, we
have shown that whole-genome association studies can also
be successfully applied to such physiological multigenic
traits as human episodic memory (9).
In this report, we provide evidence from genetic, transcrip-
tomic and functional magnetic resonance imaging (fMRI)
studies suggesting involvement of common SNPs within the
gene encoding calmodulin-binding transcription activator 1
(CAMTA1) in the modification of normal episodic human
memory performance. These SNPs were identified by further
analyzing the data of our recently reported genome-wide
screen of 502 627 SNPs (9), which was done in pooled
DNA from young adults stratified for episodic memory per-
formance (see Materials and Methods); the SNPs were verified
by individual genotyping in the identical training cohort using
a different genotyping technology, and were validated sub-
sequently in a completely independent cohort of normal
subjects.
RESULTS
Cohort 1 memory testing and genotyping
Cognitively and neurologically normal young adults from
Switzerland (n ¼ 351) were recruited for the initial pooled
genetic analysis. To control for genetic background, structured
association and genomic control analyses were performed on
the recruited individuals through the individual genotyping
of 318 SNPs. Ten individuals were identified as outliers
(with a probability of allocation to the study population
,25%) and were excluded subsequently from the association
study. The remaining population (n ¼ 341) was stratified into
four groups according to their performance on a verbal episo-
dic memory task quantifying their 5 min recall success from
a list of 30 semantically unrelated nouns. Equimolar pools
of genomic DNA from individuals in each quartile were gen-
otyped at 502 627 SNPs on the Affymetrix GeneChip
Mapping EA 500K SNP array chipset. Poorly performing
SNPs were discarded, and a single-point statistical approach
was employed to select SNPs associated with memory per-
formance. A limited number of studies have been conducted
that demonstrate it is possible to accurately predict the
allelic frequencies of a SNP from a pooled sample on a micro-
array and, in fact, identify quantitative trait loci (10–13). In
this study, we focused on the genomic region harboring
CAMTA1 (see Materials and Methods for a detailed descrip-
tion of the SNP selection criteria). A CAMTA1 SNP
(rs7547519 at chr1:7250402) yielded a high significance
value of allelic association with memory performance
(P ¼ 7  1029) at the pooling phase. In addition, an adjacent
SNP (rs7549382 at chr1:7255169) also yielded significant
results (P ¼ 0.0001). The significance value of rs7547519 sur-
vives a Bonferroni-corrected significance level (corrected
a ¼ 0.05/502 627); a correction widely considered to be too
extreme for genome-wide association studies. The pooled
analysis was undertaken as an approach to rapidly screen the
genome for plausible associated regions; therefore, individual
genotyping was employed to confirm these results in both the
training population and in an entirely new population. The
raw, pooled SNP data for the CAMTA1 locus are available
at http://www.tgen.org/neurogenomics/data.
Individual genotyping was performed on 97 tagSNPs cover-
ing 446 888 bp of the genome surrounding the locus high-
lighted in the pooled analysis in the same individuals from
Swiss cohort 1 that contributed to the above detailed pools.
The genotype chi-square P-values are illustrated in Figure 1
(in black). Two of the SNPs probed on the Affymetrix 500K
array during the pooled analysis, rs7547519 and rs7549382,
were individually genotyped in the tag SNP analysis and
their significances were found to be 0.004 and 0.0005, respect-
ively. Significant SNPs within CAMTA1, especially rs7549382
and rs947678, yielded significance levels either below or just
above the Bonferroni-corrected (for 97 tests) P-value of
0.0005.
Cohort 2 memory testing and genotyping
A new sample of 472 cognitively and neurologically normal
young adults from Switzerland (Swiss cohort 2) was tested
for visual episodic memory performance. It is important to
note that the method of episodic memory testing deliberately
differed from the first Swiss cohort, in that the individuals
were asked to recall pictures instead of words. The individual
SNP significance levels of the same 97 tag SNP panel in this
new cohort are also illustrated in Figure 1 (in red). This analy-
sis yielded two different SNPs with significance levels below
the Bonferroni-corrected P-value, rs4908449 (P ¼ 0.00002)
and rs705677 (P ¼ 0.0002). Note that this correction was for
the entire panel of tag SNPs (n ¼ 97), which is clearly an over-
correction as a large percentage of the tag SNPs is in linkage
disequilibrium (LD) with one another and are therefore not
considered to be independent tests. The individual signifi-
cances in each population are indicated for these select
SNPs in Table 1. Significances for each individually geno-
typed SNP within the locus are provided in Supplementary
Material, Table S1.
There were no allele-dependent differences in the outcomes
of the d2 cancellation test and the digit span test. The d2 can-
cellation test reliably quantifies attention and concentration,
whereas the digit span test quantifies working memory
capacity. Thus, performance in these tests mirrors the engage-
ment of brain structures different than those engaged in episo-
dic memory. We therefore conclude that rs4908449 was not
associated with attention, concentration or working memory
in this population, but specifically with episodic memory
performance.
The rs4908449 SNP is a common C! T polymorphism
located in an intron of the CAMTA1 gene (NM_015215). Hap-
lotyping analysis (using the D0 statistic) revealed 24 different
blocks in this locus, and SNP rs4908449 was in greatest
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linkage disequilibrium with haplotype block 5 (Fig. 1, bottom)
firmly located within the CAMTA1 locus, therefore, our
observed association is likely unrelated to linkage disequili-
brium with any adjacent genes.
Expression analysis of CAMTA1 in the human
and mouse brains
Expression levels of CAMTA1 in memory-related human
brain regions were determined using quantitative reverse tran-
scriptase polymerase chain reaction (RT-PCR). CAMTA1
mRNA levels were high in the temporal cortex and entorhinal
cortex, key regions in human memory processes, and in the cer-
ebellum (Fig. 2). Furthermore, in situ hybridization studies in
mice show that CAMTA1 expression is highest in the dentate
gyrus and the CA1 regions of the hippocampal formation
(Fig. 2, inset), the two brain regions thought to play critical
roles in aspects of episodic and spatial memory. Additionally,
immunohistochemical staining of CAMTA1 in human middle
temporal gyrus sections indicates that its expression is detect-
able in neurons (Fig. 3). Therefore, CAMTA1 expression
patterns in both the human and mouse brains are consistent
with a role in memory performance.
fMRI analysis of the effect of CAMTA1 alleles
on brain activity
fMRI was used to study the relation between CAMTA1 geno-
type and human memory-related brain functions. We postu-
lated that the medial temporal brain regions of persons
carrying the allele associated with poorer memory perform-
Table 1. Key associated SNPs and their P-values in the Swiss population
(cohorts 1 and 2)
SNP Chromosome 1 location P-value
Cohort 1 Cohort 2
rs4908449 7226966 0.7 0.00002
rs7547519 7250402 0.004 0.001
rs7549382 7255169 0.0005 0.15
rs705677 7344176 0.5 0.0002
rs947678 7426882 0.0006 0.9
Figure 1. Individual significance levels of tag SNPs in training and validation cohorts. Filled circles indicate the significance level of individual SNPs for each
representative population. A Bonferroni-corrected (for 97 tests) significance level of P ¼ 0.0005 is indicated by the red horizontal line. Swiss cohort one (black)
consists of individuals included during the pooled analysis training, Swiss cohort 2 (red) is individual results from the independent validation cohort. SNPs high-
lighted in this study are denoted with arrowheads. The relative genomic structure of the CAMTA1 gene is illustrated in the middle portion of the panel. Filled
boxes delineate predicted CAMTA1 coding exons. Note the region of interest is indicated by dashed connecting lines and spans exons 5–6 of CAMTA1. The
lower portion of the figure illustrates the haplotype structure of the region as assessed by Haploview 3.2. Red squares represent regions of high linkage dis-
equilibrium (high D0 values).
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ance would have to ‘work harder’ to perform memory tasks as
well as non-carriers of this allele. Thirty-five subjects from
first Swiss sample (22 rs4908449 T allele carriers versus 13 non-
carriers of the T allele) underwent fMRI. The allelic groups
were matched for sex, education, age and 5 min delayed
recall performance (all P . 0.3) in order to minimize poten-
tially confounding effects of demographic differences or differ-
ential task performance when we compared memory-task
dependent increases in regional brain activity in the two
subject groups. Furthermore, because CAMTA1 was associated
with human episodic memory that depends on the function of
the hippocampus, we hypothesized that CAMTA1 genotypes
might affect episodic memory-related information processing
in the human hippocampus (14). As neuroimaging studies
have found that the hippocampus is especially activated by
associative episodic memory tasks, the impact of the
CAMTA1 genotype on hippocampal activations in a face-
profession association task was tested (15). During memory
retrieval, carriers of the T allele showed significantly increased
brain activations compared with non-carriers in the medial tem-
poral lobe (local maximum in the right hippocampus at coordi-
nate position [24,210,216], t ¼ 4.24, P , 0.001, coordinates
according to the Montreal Neurological Institute; Fig. 4). There
were no additional increased cortical activations in carriers of
the T allele in this episodic memory task. Additionally, in a
working memory, task carriers of the T allele failed to show sig-
nificantly greater increases in the brain activity than the
non-carriers of this allele during the working memory task,
suggesting that allele-related differences in memory perform-
ance may be specifically related to some of the cognitive
operations and brain regions involved in episodic memory.
There were no greater task-related cortical activations in the
non-carriers of the T allele group compared with carriers of
the T allele and, furthermore, no allele-dependent differences
in cortical brain activations during encoding were found,
suggesting that the genotype did not affect episodic memory
during that early stage of memory formation. There were no
allele-dependent differences in volumes of the hippocampus,
suggesting that functional imaging results were not biased by
morphological differences.
DISCUSSION
Currently, little is known regarding the molecular machinery
involved in the intricate processes that enable the formation
and retrieval of memories and the corresponding genetic poly-
morphisms in the human population that lead to differential
memory performance. However, it is crucial that we begin
to investigate and understand the genetics of memory to aid
in the prediction of amnestic disease risk and also to
uncover the associated molecular pathways that may lead to
better intelligent design of memory sparing or enhancing phar-
maceuticals. It is estimated that 30 million Americans suffer
from some type of memory disorder (16). Of these, AD is the
most common, afflicting 10% of persons over the age
Figure 2. CAMTA1 expression in human and murine brain. Expression levels of CAMTA1 were measured by qRT-PCR with data normalized to glyceraldehydr-
3-phophate dehydrogenase (GAPDH) expression levels. The inset shows the expression of CAMTA1 in the murine brain as detected by in situ hybridization
(Allen Institute for Brain Science, www.brainatlas.com). (A) Nissl-stained reference brain section for (B), which illustrates a gene expression filter for
CAMTA1 (with red indicating the highest regions of expression). (C) Illustration of the relative atlas region and (D) magnified view of the raw in situ hybrid-
ization data for CAMTA1 in the hippocampal formation, the dark purple staining indicates areas of highest expression.
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of 65 years and almost half of those .85 years (17). Other
diseases with an amnestic component include Down’s syn-
drome, schizophrenia, depression, Parkinson’s disease and
epilepsy (18–23). This is all in addition to the normal
memory decline associated with the aging process. With all
of this said, there is currently only one major class of drugs
approved for use to combat memory impairment. However,
it is well known that if one could delay the onset of AD by
5 years, presumably through the use of memory-sparing phar-
maceuticals, the incidence of the disease would, in turn,
Figure 3. CAMTA1 expression in middle temporal gyrus human brain sections. CAMTA1 staining was performed in frozen middle temporal gyrus sections from
neurological normal adults. Sections exposed only to secondary antibody were investigated as controls (not shown). Note CAMTA1-positive cells (brown stain-
ing) of varying morphologies. The included scale bar is representative for all of the panels shown.
Figure 4. CAMTA1 allele-dependent differences in episodic-memory-related hippocampal activation as measured with fMRI. The figure illustrates significantly
greater activations in the right hippocampus of carriers of the T allele (n ¼ 22) than in non-carriers of the T allele (n ¼ 13) of SNP rs4908449 during a face-
profession associative memory task. Activations were overlaid on a coronal section of a T1-weighted MR image of SPM2 and displayed in color-coded t-values
(see bar). Threshold: P, .001. H: hippocampus; L/R: left/right side of brain.
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decrease by 50% (24). All of this points to a growing need to
better understand the genes and proteins participating in the
normal intact process of memory.
To begin to address this need, we performed a pooling-
based whole-genome association study in cognitively normal
individuals stratified by episodic memory performance. The
use of a pooled association study design was undertaken,
because it affords a rapid, cost-effective approach for the
identification of the top, several, significantly associated
regions (11,13,25,26). However, the use of such an experimen-
tal design is admittedly not ideal for genome-wide association
since by its nature all individual haplotyping ability is lost by
the pooled approach. In any case the important aspect to
realize is that the pooled approach is an effective prioritization
strategy that requires subsequent individual genotyping vali-
dation and replication of any associated SNP(s). In this
study, we performed individual genotyping in two indepen-
dent populations to identify the significantly associated
SNPs. CAMTA1 association through the use of the same train-
ing cohort was detailed in our previous study, highlighting the
association of KIBRA with episodic memory (9). Of note,
CAMTA1 SNPs were significantly associated with human epi-
sodic memory performance irrespective of modality of the
task (i.e. verbal or visual episodic memory). We also report
here the identification of significant SNPs within the same
genetic locus that differ between our two seemingly geneti-
cally homogeneous cohorts. This is a common observation
in association studies of polygenic phenotypes and diseases,
as was also shown in a recent study on the association of
SORL1 with AD (27).
The associated gene, CAMTA1, is a member of the family
of calmodulin-binding transcriptional activators (CAMTAs),
shown to be conserved across a wide range of multi-
cellular eukaryotes including Arabidopsis, Drosophila and
Caenorhabditis in addition to humans (28,29). Human
CAMTA family members encode for four main protein
domains, including a transcription factor immunoglobulin
(TIG)-like DNA-binding domain, calmodulin-binding IQ
motifs, ankyrin repeats and the family-specific DNA-binding
domain termed as CG-1 that contains a bipartite nuclear local-
ization signal (29). The majority of the published literature on
CAMTA1 in humans has focused on its purported role as a
tumor suppressor gene in neuroblastoma patients where its
genomic deletion and lowered expression were found to be
significantly associated with poor clinical outcome (30–33).
Other CAMTA1 biology in humans is still poorly understood;
however, in Arabidopsis it was shown that CAMTAs are able
to bind double-stranded DNA and calmodulin, are primarily
localized to the nucleus and could activate transcription
(29). Calcium-responsive proteins including CREB, calci-
neurin, CAMKII and calmodulin have an established role in
neuronal plasticity, LTP, and learning and memory across
multiple organisms (34–39). Polymorphisms in a calcium-
responsive transcriptional activator, as described herein,
suggest a mechanism involving differential regulation of
genes that may participate in the downstream more lasting
changes involved in long-term memory. Our findings illus-
trated here demonstrate an association between a CAMTA1
allele and a differential performance in normal episodic
memory, and raise the possibility of adding CAMTA1 to the
list of calcium-responsive proteins that are responsible for
the process of memory in humans. Additional studies are
needed to confirm its role in the modulation of episodic
memory performance, how it may be related to the memory
changes associated with normal brain aging and several neuro-
logical and psychiatric disorders and the extent to which it can
be used to identify promising memory-enhancing treatments.
MATERIALS AND METHODS
Study subjects and memory testing
Cohort 1. Memory testing and genotyping were performed in
351 cognitively and neurologically normal young adults from
Switzerland (240 females, 111 males; median age, 22 years;
range, 18–48 years). Subjects viewed six series of five seman-
tically unrelated nouns presented at a rate of one word per
second with the instruction to learn the words for immediate
free recall after each series; additionally, subjects underwent
an unexpected, delayed free-recall test of the learned words
after 5 min and again after 24 h.
Cohort 2. Memory testing and genotyping were performed in
472 other cognitively and neurologically normal young adults
from Switzerland (353 females, 119 males; median age,
21 years; range, 16–28 years). In this study, however, the sub-
jects were presented 10 semantically unrelated pictures at a
rate of one picture per 4 s and delayed free recall was tested
after 10 min. Attention and concentration with the d2 cancel-
lation test and working memory with the digit span task were
assessed.
Assessment of genetic background
Structured association analysis was performed by individually
genotyping all 351 subjects from Swiss cohort 1 at 318
unlinked SNPs. Calculation of population structure was per-
formed using the STRUCTURE program (40). We estimated
the ancestry of study subjects under the a priori assumption
of K ¼ 2 discrete subpopulations. Structured association
analysis revealed moderate allele-frequency divergence
among populations. Identical results were obtained under the
a priori assumption of 3  K  6 discrete subpopulations.
Affymetrix 500k genechip SNP genotyping in cohort 1
Individual genomic DNA concentrations were determined
with the PicoGreen dsDNA Assay Kit (Invitrogen, Carlsbad,
California, USA). Individuals were designated to each pool
based on their quartile ranking in 5 min free recall on the
verbal episodic memory task. Each individual contributed a
total of 120 ng of DNA to the pool, and each pool was
created de novo a total of three times. These three pools
were then genotyped in duplicate on both the Early Access
500K Mendel array from Affymetrix (Santa Clara, CA,
USA) as described in the Early Access Version 2.0 of the
Mendel Array protocol.
1474 Human Molecular Genetics, 2007, Vol. 16, No. 12
Statistical analysis of pooled genotyping data
Calculation of a SNP’s allelic frequency was based on its cor-
responding relative allele signal (RAS) score used previously
to calculate allele frequencies in pooled DNA (11,13).
RAS values were generated for each SNP using a specifically
developed, freely available PERL script (http://
bioinformatics.tgen.org/software/tgen-array/). RAS-derived
allelic frequencies were used to calculate SNP-specific
x2-values for following comparisons: top 50% versus bottom
50% performers (entire sample) and top 25% versus bottom
25% performers (distribution extremes). Because RAS1 and
RAS2 values were treated independently, statistics for each
SNP were calculated a total of four times. SNPs fulfilling the
following criteria in at least one of the four comparisons were
considered significant: x2  28, df ¼ 1 (corresponding to
P  0.05, Bonferroni corrected for 500 000 comparisons), vari-
ation coefficient of RAS-derived allelic frequencies  0.2 (see
Supplementary Material, Figure S1). Of the 1308 SNPs fulfill-
ing the above-mentioned criteria, SNPs within CAMTA1 were
considered promising targets because CAMTA1 protein binds
calmodulin, a key player in synaptic plasticity. In contrast to
our previous study, the 1308 significant SNPs were not tested
by a second data reduction method (i.e. sliding window). The
decision to follow up on CAMTA1 SNPs was based on the
candidate nature of this gene and on neurobiological
considerations.
Individual genotyping
Genotyping was performed either by Pyrosequencing
(Uppsala, Sweden) on a PSQ 96 MA machine and/or by the
Amplifluor method (www.kbiosciences.com). Haploview 3.2
was used for the analysis of linkage disequilibrium and haplo-
type reconstruction. Multifactorial analyses of variance were
performed for the simultaneous assessment of the influence
of age, sex, education and genotype effects on cognitive test
performance. All tests were two-tailed.
Human gene expression studies CAMTA1 quantitative
reverse transcriptase polymerase chain reaction (qRT-PCR)
was performed on an ABI PRISM 7700 TaqMan machine
(ABI, Foster City, CA, USA) with SYBR master mix (Strata-
gene, Gebouw California, Amsterdam, The Netherlands).
cDNA from human brain regions was purchased from
BioCat (BioCat GmbH, Im Neuenheimer Feld, Heidelberg,
Germany). Primers were designed by PrimerDesign [(v1.9,
ABI), primer details are available on request]. RNA was
obtained from commercially available histopathologically
normal human brain tissue (www.biocat.de and www.
clontech.com; four donors, median age at death, 27.5 years;
range, 24–60 years).
CAMTA1 immunohistochemistry
Frozen middle temporal gyrus brain sections were obtained
through collaboration with the Sun Health Research Institute
(Sun City, AZ, USA). All donors were cleared as neurologi-
cally normal based on clinical interview prior to death in
addition to pathological screening for molecular markers of
degeneration and disease, such as neuronal plaques and
tangles, after death. Sections were allowed to warm to room
temperature, were fixed for 5 min in acetone in room tempera-
ture, equilibrated in Tris-buffered saline (TBS, 50 mM Tris,
138 mM NaCl, 2.7 mM KCl, pH 8.0) and exposed to 3% hydro-
gen peroxide in TBS for 10 min at room temperature to block
endogenous peroxidase activity. Sections were rinsed with
TBS containing 0.05% Tween 20 (TBST), and slide pairs
were constructed for the Shandon Sequenza capillary gap
staining system (Thermo Electron Corporation, Waltham,
MA, USA). The Vectastain ABC rat IgG kit (Vector Labora-
tories, Burlingame, CA, USA) was used to detect the CAMTA1
signal. Slide pairs were incubated with 200 ml of 10% normal
horse serum in TBST for 10 min. Slides were then incubated
with 100 ml of 1:100 dilutions of anti-CAMTA1 primary anti-
bodies (a generous gift of Dr Kaname Nakatani, Mie Univer-
sity School of Medicine, Japan) in TBST with 10% normal
horse serum for 2 h. After the first hour, the primary antibody
solution was refreshed with an additional 100 ml of
anti-CAMTA1 primary antibodies. Secondary only control
sections were incubated with TBST with normal horse
serum during this period. Slides were then rinsed with 2 ml
of TBST and incubated with 200 ml of 1:200 diluted anti-rat
secondary antibodies for 30 min (Vector Laboratories). After
rinsing with TBST, slides were incubated with 3,3’-diamino-
benzidine tetrahydrochloride (DAB) chromogen for 10 min.
Sections were rinsed with TBST, incubated for 5 s in undiluted
hematoxylin counter-stain, rinsed again with TBST and then
with distilled water. Slides were then dehydrated in increasing
percentages of ethanol and finally into to xylene prior to
mounting and imaging.
Functional magnetic resonance imaging
Subjects. Twelve males, 23 females; median age, 22 years;
range, 19–32 years.
Episodic memory task. We presented 16 face-profession pairs
for associative learning and 24 head contours without physiog-
nomy in the visual baseline condition. Both the baseline con-
dition and the learning condition were given in three
consecutive learning runs (three separate fMRI time series).
The order of conditions and stimuli was constant across the
three runs. For associative learning of the face-profession
pairs, subjects were instructed to imagine the presented
person acting in a scene of the written profession. Subjects
answered by button press (with their dominant hand)
whether they found it easy or hard to imagine a scene. Sub-
jects were requested to imagine the same scene for a given
face-profession pair during runs 2 and 3 as during run 1.
The visual baseline task was to decide whether the area of
the left or right ear was larger. The sequence of conditions
within the fMRI time-series was counterbalanced across sub-
jects. Both the learning and the baseline condition consisted
of four blocks. In the learning condition, a block contained
four stimuli of 6 s each. In the baseline condition, a block con-
tained six stimuli of 4 s each. An instruction slide announced
each task block. For memory retrieval, we applied a single
fMRI time series. This time series included an associative
retrieval condition and the same visual baseline condition
that was used for the encoding time series. For the retrieval
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of the associations, the previously presented faces were shown
again (without the professions) as retrieval cues with the
instruction to recall each person’s occupation and to indicate
the superordinate professional category by button press: aca-
demic or workman. The sequence of conditions within the
fMRI time series was counterbalanced across subjects. The
retrieval condition consisted of four blocks, each block includ-
ing four stimuli of 6 s each. All task blocks took 24 s and were
announced by an instruction slide.
Working memory. The experiment included one fMRI time
series with a 2-back task for the assessment of working
memory and a baseline task (‘x-target’) for the assessment
of concentration. The 2-back task required subjects to
respond to a letter repeat with one intervening letter (S—f—
s—g). The ‘x-target’ task required subjects to respond to the
occurrence of the letter ‘x’. Each task was given in five
blocks of 26 s each. Blocks were announced by an instruction
slide. Stimuli were 50 upper- or lowercase letters typed in
black on a white background. Thirteen upper- or lowercase
letters were presented per block for the duration of 2 s each.
Data acquisition. Magnetic resonance measurements were
performed on a 3 T Philips Intera whole-body MR scanner
equipped with an eight-channel Philips SENSE head coil.
Functional data were obtained from 32 transverse slices
parallel to the AC-PC plane covering the whole brain with a
measured spatial resolution of 2.8  2.8  4 mM3 (acquisi-
tion matrix 80  80) and a reconstructed resolution of
1.7  1.7  4 mM3. Data were acquired with a SENSE-sshEPI
sequence with an acceleration factor of R ¼ 2.0 (41). Other
scan parameters were echo time (TE) ¼ 35 ms, scan repeat
time (TR) ¼ 3000 ms, u ¼ 828. A standard, three-dimensional
T1-weighted scan was obtained for anatomical reference with
a measured spatial resolution of 1  1  1.5 mM3 (acquisition
matrix 224  224) and a reconstructed resolution of
0.9  0.9  0.8 mM3, TE ¼ 2.3 ms, TR ¼ 20 ms, u ¼ 08. A
two-dimensional, T1-weighted inversion-recovery anatomical
scan, oriented perpendicularly to the long axis of the hippo-
campus, was obtained for hippocampal and parahippocampal
volumetry over 33–39 slices with a measured spatial resol-
ution of 0.5  0.6  1.5 mM3 (acquisition matrix 400  320)
and a reconstructed spatial resolution of
0.4  0.4  1.5 mM3, TE ¼ 5 ms, TR ¼ 4200 ms, u ¼ 208,
IR delay 400 ms and no interslice gaps.
Analysis of fMRI data. Image pre- and postprocessing and the
statistical analyses were performed with SPM2. Standard pre-
processing procedures were applied, realignment, normaliza-
tion and spatial smoothing (8 mM) (42). On the single
subject level, data were analyzed according to the fixed
effects model (SPM2). The six head movement parameters
were included in the model as confounding factors. Data
were high-pass filtered with a specific filter value for each
fMRI time series. This value was determined according to
‘2SOATR’. On the second level, within-subject contrasts
were entered into random effects analyses (ANOVAs, t-tests,
SPM2), which account for variance between subjects (43).
Thresholds were set at a P , 0.001 level, uncorrected for
multiple comparisons, which is a widely used threshold for
activations within the medial temporal lobe. Only activations
with ,5 voxels were considered. SPM2 coordinates refer to
standard brains from the Montreal Neurological Institute.
Analysis of anatomical MRI data. On the basis of the three-
dimensional, T1-weighted structural MRI images, which
covered the whole brain, volumes of the total gray and
white matter, were computed with SPM2. Images were first
normalized into the Montreal Neurological Institute (MNI)
T1 template with a standard bounding box and then segmented
into gray matter, white matter and cerebrospinal fluid. Stan-
dardized gray and white matter volumes were then multiplied
by the determinant of the linear transformation matrix to
obtain gray and white matter volumes in cubic centimeter.
On the basis of the two-dimensional, T1-weighted, high-
resolution structural MRI images, two independent raters
manually delineated the hippocampal formation (CA
regions, dentate gyrus and subiculum, excluding the fimbria)
and the parahippocampal gyrus using the software Pmod
(14). Cerebrospinal fluid was carefully excluded, resulting in
conservative volume estimates. Raters relied on descriptions
of anatomical landmarks and subdivisions of the MTL as
described earlier (44). Inter-rater reliabilities ranged between
r ¼ 0.8 and 0.98.
SUPPLEMENTARY MATERIAL
Supplementary material is available at HMG Online.
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